|
C14ORF145 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.504400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.768800E-01 |
| Normal-vs-Stage2 |
7.942800E-01 |
| Normal-vs-Stage3 |
4.815200E-01 |
| Normal-vs-Stage4 |
3.869400E-01 |
| Stage1-vs-Stage2 |
9.500800E-01 |
| Stage1-vs-Stage3 |
2.659600E-01 |
| Stage1-vs-Stage4 |
4.947800E-01 |
| Stage2-vs-Stage3 |
4.460400E-01 |
| Stage2-vs-Stage4 |
6.289400E-01 |
| Stage3-vs-Stage4 |
2.669800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.585600E-01 |
| Normal-vs-AfricanAmerican |
9.065000E-01 |
| Normal-vs-Asian |
7.109000E-01 |
| Caucasian-vs-AfricanAmerican |
9.267800E-01 |
| Caucasian-vs-Asian |
7.648000E-01 |
| AfricanAmerican-vs-Asian |
7.877200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.104000E-01 |
| Normal-vs-Female |
1.106380E-01 |
| Male-vs-Female |
1.496440E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.541400E-01 |
| Normal-vs-Extreme_Weight |
3.258000E-01 |
| Normal-vs-Obese |
1.188230E-01 |
| Normal-vs-Extreme_Obese |
1.308960E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.975000E-01 |
| Normal_Weight-vs-Obese |
1.248320E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.271000E-01 |
| Extreme_Weight-vs-Obese |
5.997000E-03 |
| Extreme_Weight-vs-Extreme_Obese |
4.308800E-01 |
| Obese-vs-Extreme_Obese |
8.881700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.934400E-02 |
| Normal-vs-Age(41-60Yrs) |
2.331000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.904200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.460030E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.076990E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.205800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.647800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.363000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.518200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.599400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.865000E-01 |
| Normal-VS-Type2 PRCC |
3.178400E-02 |
| Normal-VS-KIRP CIMP |
2.133000E-01 |
| Normal-VS-Unclassified PRCC |
1.939560E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.242200E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.505200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.494200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.226200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.118900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.742200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.588300E-02 |
| Normal-vs-N1 |
7.519900E-02 |
| Normal-vs-N2 |
1.126240E-01 |
| N0-vs-N1 |
8.264700E-03 |
| N0-vs-N2 |
3.503400E-01 |
| N1-vs-N2 |
1.117150E-03 |
|
|
